ACMT Comment on Recent Guidance on PFAS Laboratory Testing

John W Downs^{1

2}, Nicholas E Nacca³, Andrew I Stolbach⁴, Michael G Holland⁵

Affiliations

¹ Division of Clinical Toxicology, Department of Emergency Medicine, Virginia Commonwealth University Health System, Richmond, VA, USA. positionstatements@acmt.net.
² Division of Clinical Toxicology, Virginia Commonwealth University Health System, 23298, Richmond, VA, USA. positionstatements@acmt.net.
³ Departments of Emergency Medicine and Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA.
⁴ Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁵ Department of Emergency Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.

John W Downs et al. J Med Toxicol. 2024.

. 2024 Jul 27;20(3):334-335.

doi: 10.1007/s13181-024-01004-1. Epub 2024 Apr 18.

John W Downs^{1

2}, Nicholas E Nacca³, Andrew I Stolbach⁴, Michael G Holland⁵

¹ Division of Clinical Toxicology, Department of Emergency Medicine, Virginia Commonwealth University Health System, Richmond, VA, USA. positionstatements@acmt.net.
² Division of Clinical Toxicology, Virginia Commonwealth University Health System, 23298, Richmond, VA, USA. positionstatements@acmt.net.
³ Departments of Emergency Medicine and Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA.
⁴ Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁵ Department of Emergency Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.

No abstract available

Keywords: Alkanesulfonic acids; Caprylates; Clinical laboratory testing; Perfluorooctane sulfonic acid (PFOS); Perfluorooctanoic acid (PFOA).

Conflict of interest statement

JWD, NEN, AIS and MGH declare no personal or family conflicts of interest.

1. Agency for Toxic Substances and Disease Registry (ATSDR). PFAS Information for Clinicians [Internet]. 2024. Accessed 1 February 2024. https://www.atsdr.cdc.gov/pfas/resources/pfas-information-for-clinicians....
1. Zahm S, Bonde JP, Chiu WA, et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol. 2024;25(1):16–7. 10.1016/S1470-2045(23)00622-8 - DOI - PMC - PubMed
1. National Academies of Sciences, Engineering, and Medicine (NASEM). Guidance on PFAS exposure, testing, and clinical Follow-Up. Washington (DC): National Academies; 2022. - PubMed
1. Barry V, Winquist A, Steenland K. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect. 2013;121(11–12):1313–8. 10.1289/ehp.1306615 - DOI - PMC - PubMed
1. Lucas K, Gaines L, Paris-Davila T, et al. Occupational exposure and serum levels of per- and polyfluoroalkyl substances (PFAS): a review. Am J Ind Med. 2023;66(5):379–92. 10.1002/ajim.23454 - DOI - PubMed